1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PHARMING GROUP N.V. - ADR
18.02 -0.76 (-4.05%)
31,135
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Pharming Grp N.V. (ADR) - PHAR - stock price prediction, stock price target, analyst ratings from 3 analysts

Pharming Grp N.V. (ADR) has a share price target of US$ 31, revenue growth forecast of 34.7%, and profit growth estimate of 192.2% for FY25, based on top 3 analyst calls.